These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19776763)

  • 1. Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines.
    Wilcox RA; Sun DX; Novak A; Dogan A; Ansell SM; Feldman AL
    Leukemia; 2010 Jan; 24(1):229-32. PubMed ID: 19776763
    [No Abstract]   [Full Text] [Related]  

  • 2. Spleen tyrosine kinase mediates BEAS-2B cell migration and proliferation and human rhinovirus-induced expression of vascular endothelial growth factor and interleukin-8.
    Wang X; Mychajlowycz M; Lau C; Gutierrez C; Scott JA; Chow CW
    J Pharmacol Exp Ther; 2012 Feb; 340(2):277-85. PubMed ID: 22031919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target.
    Young RM; Hardy IR; Clarke RL; Lundy N; Pine P; Turner BC; Potter TA; Refaeli Y
    Blood; 2009 Mar; 113(11):2508-16. PubMed ID: 18981293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
    Friedberg JW; Sharman J; Sweetenham J; Johnston PB; Vose JM; Lacasce A; Schaefer-Cutillo J; De Vos S; Sinha R; Leonard JP; Cripe LD; Gregory SA; Sterba MP; Lowe AM; Levy R; Shipp MA
    Blood; 2010 Apr; 115(13):2578-85. PubMed ID: 19965662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation.
    Chen L; Juszczynski P; Takeyama K; Aguiar RC; Shipp MA
    Blood; 2006 Nov; 108(10):3428-33. PubMed ID: 16888096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healing the Syk through kinase inhibitors.
    Rivera J; Colbert RA
    N Engl J Med; 2010 Sep; 363(14):1362-4. PubMed ID: 20879886
    [No Abstract]   [Full Text] [Related]  

  • 7. SYK inhibition and response prediction in diffuse large B-cell lymphoma.
    Cheng S; Coffey G; Zhang XH; Shaknovich R; Song Z; Lu P; Pandey A; Melnick AM; Sinha U; Wang YL
    Blood; 2011 Dec; 118(24):6342-52. PubMed ID: 22025527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth.
    Gururajan M; Dasu T; Shahidain S; Jennings CD; Robertson DA; Rangnekar VM; Bondada S
    J Immunol; 2007 Jan; 178(1):111-21. PubMed ID: 17182546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis.
    Fruchon S; Kheirallah S; Al Saati T; Ysebaert L; Laurent C; Leseux L; Fournié JJ; Laurent G; Bezombes C
    Leukemia; 2012 Apr; 26(4):795-805. PubMed ID: 21926965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia.
    Buchner M; Baer C; Prinz G; Dierks C; Burger M; Zenz T; Stilgenbauer S; Jumaa H; Veelken H; Zirlik K
    Blood; 2010 Jun; 115(22):4497-506. PubMed ID: 20335218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syk is downstream of intercellular adhesion molecule-1 and mediates human rhinovirus activation of p38 MAPK in airway epithelial cells.
    Wang X; Lau C; Wiehler S; Pow A; Mazzulli T; Gutierrez C; Proud D; Chow CW
    J Immunol; 2006 Nov; 177(10):6859-70. PubMed ID: 17082600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
    Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S
    Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a novel system for studying spleen tyrosine kinase function in macrophages and B cells.
    Miller AL; Zhang C; Shokat KM; Lowell CA
    J Immunol; 2009 Jan; 182(2):988-98. PubMed ID: 19124742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syk kinase inhibitors in allergic diseases.
    Denyer J; Patel V
    Drug News Perspect; 2009 Apr; 22(3):146-50. PubMed ID: 19440557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syk inhibitors.
    Chihara K; Kimura Y; Honjo C; Takeuchi K; Sada K
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(4):197-202. PubMed ID: 23994797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jak3 contributes to the activation of ALK and Stat3 in ALK(+) anaplastic large cell lymphoma.
    Amin HM; Lin Q; Lai R
    Lab Invest; 2006 Apr; 86(4):417-9; author reply 420-1. PubMed ID: 16554750
    [No Abstract]   [Full Text] [Related]  

  • 17. Membrane-associated signaling in human B-lymphoma lines.
    Tauzin S; Ding H; Burdevet D; Borisch B; Hoessli DC
    Exp Cell Res; 2011 Jan; 317(2):151-62. PubMed ID: 20875408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro efficacy of tyrosine kinase inhibitors: SYK and BCR-ABL inhibitors in lymphomas.
    Rinaldi A; Ponzoni M; Uccella S; Rossi D; Gaidano G; Facchetti F; Pruneri G; Tibiletti MG; Capella C; Zucca E; Doglioni C; Catapano C; Bertoni F
    Hematol Oncol; 2011 Sep; 29(3):164-6. PubMed ID: 21416481
    [No Abstract]   [Full Text] [Related]  

  • 19. TrkA is a binding partner of NPM-ALK that promotes the survival of ALK
    Shi W; George SK; George B; Curry CV; Murzabdillaeva A; Alkan S; Amin HM
    Mol Oncol; 2017 Sep; 11(9):1189-1207. PubMed ID: 28557340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein.
    Ergin M; Denning MF; Izban KF; Amin HM; Martinez RL; Saeed S; Alkan S
    Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.